Microstructural changes observed with DKI in a transgenic Huntington rat model: Evidence for abnormal neurodevelopment

Huntington Disease (HD) is a fatal neurodegenerative disorder, caused by a mutation in the Huntington gene. Although HD is most often diagnosed in mid-life, the key to its clinical expression may be found during brain maturation. In the present work, we performed in vivo diffusion kurtosis imaging (DKI) in order to study brain microstructure alterations in developing transgenic HD rat pups. Several developing brain regions, relevant for HD pathology (caudate putamen, cortex, corpus callosum, external capsule and anterior commissure anterior), were examined at postnatal days 15 (P15) and 30 (P30), and DKI results were validated with histology. At P15, we observed higher mean (MD) and radial (RD) diffusivity values in the cortex of transgenic HD rat pups. In addition, at the age of P30, lower axial kurtosis (AK) values in the caudate putamen of transgenic HD pups were found. At the level of the external capsule, higher MD values at P15 but lower MD and AD values at P30 were detected. The observed DKI results have been confirmed by myelin basic protein immunohistochemistry, which revealed a reduced fiber staining as well as less ordered fibers in transgenic HD rat pups. These results indicate that neuronal development in young transgenic HD rat pups occurs differently compared to controls and that the presence of mutant huntingtin has an influence on postnatal brain development. In this context, various diffusivity parameters estimated by the DKI model are a powerful tool to assess changes in tissue microstructure and detect developmental changes in young transgenic HD rat pups.

[1]  J. Helpern,et al.  Three‐dimensional characterization of non‐gaussian water diffusion in humans using diffusion kurtosis imaging , 2006, NMR in biomedicine.

[2]  Yoram Cohen,et al.  QSI and DTI of excised brains of the myelin-deficient rat , 2009, NeuroImage.

[3]  J. Kordower,et al.  Early changes in Huntington’s disease patient brains involve alterations in cytoskeletal and synaptic elements , 2004, Journal of neurocytology.

[4]  Paolo Guidetti,et al.  Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease , 2010, Progress in Neurobiology.

[5]  Sandrine Humbert Is Huntington disease a developmental disorder? , 2010, EMBO reports.

[6]  Anil Kumar,et al.  Huntington’s disease: pathogenesis to animal models , 2010, Pharmacological reports : PR.

[7]  Stephan E Maier,et al.  Developmental changes and injury induced disruption of the radial organization of the cortex in the immature rat brain revealed by in vivo diffusion tensor MRI. , 2007, Cerebral cortex.

[8]  R H Myers,et al.  Decreased Neuronal and Increased Oligodendroglial Densities in Huntington's Disease Caudate Nucleus , 1991, Journal of neuropathology and experimental neurology.

[9]  Sarah A. J. Reading,et al.  Regional white matter change in pre-symptomatic Huntington's disease: A diffusion tensor imaging study , 2005, Psychiatry Research: Neuroimaging.

[10]  P G Bhide,et al.  Expression of Normal and Mutant Huntingtin in the Developing Brain , 1996, The Journal of Neuroscience.

[11]  S. Floresco,et al.  Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes , 1995, Cell.

[12]  E. Wu,et al.  MR diffusion kurtosis imaging for neural tissue characterization , 2010, NMR in biomedicine.

[13]  Ryuta Ito,et al.  Maturational changes in diffusion anisotropy in the rat corpus callosum: Comparison with quantitative histological evaluation , 2008, Journal of magnetic resonance imaging : JMRI.

[14]  Peng Yu,et al.  Altered white matter microstructure in the corpus callosum in Huntington's disease: Implications for cortical “disconnection” , 2010, NeuroImage.

[15]  Hao Huang,et al.  Three-dimensional anatomical characterization of the developing mouse brain by diffusion tensor microimaging , 2003, NeuroImage.

[16]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[17]  Vincent A Magnotta,et al.  Morphology of the cerebral cortex in preclinical Huntington's disease. , 2007, The American journal of psychiatry.

[18]  M. Hayden,et al.  Wild‐type huntingtin protects neurons from excitotoxicity , 2006, Journal of neurochemistry.

[19]  Jan Sijbers,et al.  A complementary diffusion tensor imaging (DTI)-histological study in a model of Huntington's disease , 2012, Neurobiology of Aging.

[20]  Paul M. Pilowsky,et al.  Retrograde Tracing with Cholera Toxin B–Gold or with Immunocytochemically Detected Cholera Toxin B in Central Nervous System , 1992 .

[21]  Kevin C. Chan,et al.  Does diffusion kurtosis imaging lead to better neural tissue characterization? A rodent brain maturation study , 2009, NeuroImage.

[22]  J. Helpern,et al.  Diffusional kurtosis imaging: The quantification of non‐gaussian water diffusion by means of magnetic resonance imaging , 2005, Magnetic resonance in medicine.

[23]  Ronald Wetzel,et al.  Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. , 2006, Human molecular genetics.

[24]  M. Solaiyappan,et al.  Diffusion tensor imaging of the developing mouse brain , 2001, Magnetic resonance in medicine.

[25]  M. Mehler,et al.  Mechanisms underlying neural cell death in neurodegenerative diseases: alterations of a developmentally-mediated cellular rheostat , 2000, Trends in Neurosciences.

[26]  J. Thiran,et al.  Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.

[27]  Klaus Seppi,et al.  Diffusion‐weighted imaging in Huntington's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[28]  P. Hüppi,et al.  Diffusion tensor imaging of normal and injured developing human brain ‐ a technical review , 2002, NMR in biomedicine.

[29]  P. Conn Methods in neurosciences , 1991 .

[30]  R H Myers,et al.  Quantitative neuropathological changes in presymptomatic Huntington's disease , 2001, Annals of neurology.

[31]  Elena Cattaneo,et al.  Molecular mechanisms and potential therapeutical targets in Huntington's disease. , 2010, Physiological reviews.

[32]  Ronald Wetzel,et al.  Imaging polyglutamine deposits in brain tissue. , 2006, Methods in enzymology.

[33]  A. Aron,et al.  Contrasting gray and white matter changes in preclinical Huntington disease , 2010, Neurology.

[34]  L. Raymond,et al.  N-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease , 2007, Progress in Neurobiology.

[35]  Ed X. Wu,et al.  Towards better MR characterization of neural tissues using directional diffusion kurtosis analysis , 2008, NeuroImage.

[36]  C. Beaulieu,et al.  The basis of anisotropic water diffusion in the nervous system – a technical review , 2002, NMR in biomedicine.

[37]  Christian Beaulieu,et al.  Diffusion tensor imaging of neurodevelopment in children and young adults , 2005, NeuroImage.

[38]  Thomas Walther,et al.  Transgenic rat model of Huntington's disease. , 2003, Human molecular genetics.

[39]  J. Helpern,et al.  Diffusion tensor imaging in fixed brain tissue at 7.0 T , 2003, NMR in biomedicine.

[40]  Michael R. Hayden,et al.  Mutant Huntingtin Enhances Excitotoxic Cell Death , 2001, Molecular and Cellular Neuroscience.

[41]  Virginia E. Papaioannou,et al.  Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue , 1995, Nature Genetics.

[42]  Lili Zhou,et al.  Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Andrea Ciarmiello,et al.  Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[44]  G. Elder,et al.  Schwann cells and oligodendrocytes read distinct signals in establishing myelin sheath thickness , 2001, Journal of neuroscience research.

[45]  Jean-Marie Bonny,et al.  In vivo analysis of the post‐natal development of normal mouse brain by DTI , 2007, NMR in biomedicine.

[46]  Jim Mintz,et al.  Myelin Breakdown and Iron Changes in Huntington’s Disease: Pathogenesis and Treatment Implications , 2007, Neurochemical Research.

[47]  G. Bates,et al.  Huntingtin and the molecular pathogenesis of Huntington's disease , 2004, EMBO reports.

[48]  Ines Blockx,et al.  Genotype specific age related changes in a transgenic rat model of Huntington's disease , 2011, NeuroImage.

[49]  Wilhelm Gaus,et al.  Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis , 2004, Neurology.

[50]  Andrea Ciarmiello,et al.  Seeking Brain Biomarkers for Preventive Therapy in Huntington Disease , 2011, CNS neuroscience & therapeutics.

[51]  Mario Mascalchi,et al.  Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. , 2004, Radiology.

[52]  Bin Zhang,et al.  Requirement of Heavy Neurofilament Subunit in the Development of Axons with Large Calibers , 1998, The Journal of cell biology.

[53]  Adriana Di Martino,et al.  Age‐related non‐Gaussian diffusion patterns in the prefrontal brain , 2008, Journal of magnetic resonance imaging : JMRI.

[54]  D. Rice,et al.  Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. , 2000, Environmental health perspectives.

[55]  Anne-Catherine Bachoud-Lévi,et al.  Motor and cognitive improvements in patients with Huntington's disease after neural transplantation , 2000, The Lancet.

[56]  David S Tuch,et al.  Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures , 2006, Movement disorders : official journal of the Movement Disorder Society.

[57]  W. Le,et al.  The Importance of Titrating Antibodies for Immunocytochemical Methods , 2008, Current protocols in neuroscience.

[58]  Fahmeed Hyder,et al.  Neurodevelopment of C57B/L6 mouse brain assessed by in vivo diffusion tensor imaging , 2007, NMR in biomedicine.

[59]  Wenzhen Duan,et al.  Peroxisome-Proliferator-Activated Receptor Gamma Coactivator 1 α Contributes to Dysmyelination in Experimental Models of Huntington's Disease , 2011, The Journal of Neuroscience.

[60]  M. Johnston,et al.  Quinolinate-induced injury is enhanced in developing rat brain. , 1994, Brain research. Developmental brain research.

[61]  P A Narayana,et al.  Early postnatal development of rat brain: In vivo diffusion tensor imaging , 2008, Journal of neuroscience research.

[62]  Derek K. Jones,et al.  Diffusion‐tensor MRI: theory, experimental design and data analysis – a technical review , 2002 .

[63]  U. Kumar,et al.  Differential expression of Huntington's disease gene (IT15) mRNA in developing rat brain. , 2004, Brain research. Molecular brain research.

[64]  Jane S. Paulsen,et al.  Brain Structure in Preclinical Huntington’s Disease , 2006, Biological Psychiatry.

[65]  G. Bernhard Landwehrmeyer,et al.  IT15 gene expression in fetal human brain , 1994, Brain Research.

[66]  Sarah A. J. Reading,et al.  Functional brain changes in presymptomatic Huntington's disease , 2004, Annals of neurology.

[67]  Richard S. J. Frackowiak,et al.  Magnetic resonance imaging of Huntington's disease: preparing for clinical trials , 2009, Neuroscience.

[68]  Timothy Edward John Behrens,et al.  In vivo evidence for the selective subcortical degeneration in Huntington's disease , 2009, NeuroImage.

[69]  P. Basser,et al.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. , 1996, Journal of magnetic resonance. Series B.

[70]  C. Ross,et al.  Huntington's disease: from molecular pathogenesis to clinical treatment , 2011, The Lancet Neurology.

[71]  A. Joyner,et al.  Inactivation of the mouse Huntington's disease gene homolog Hdh. , 1995, Science.

[72]  G. Egan,et al.  Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease , 2008, Brain Research Reviews.

[73]  Elsdon Storey,et al.  Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex , 1992, Journal of the Neurological Sciences.

[74]  Jeffrey H Kordower,et al.  Human neural stem cell transplants improve motor function in a rat model of Huntington's disease , 2004, The Journal of comparative neurology.

[75]  J. Olney,et al.  Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.